Company Filing History:
Years Active: 2013-2016
Title: Innovations by Christopher Mikkelson in Blood Separation Technology
Introduction
Christopher Mikkelson is an accomplished inventor based in Round Lake Beach, Illinois. He has made significant contributions to the field of blood separation technology, holding two patents that enhance the efficiency and safety of blood component management.
Latest Patents
Mikkelson's latest patent focuses on the control of the interface between separated blood components under lipemic and hemolytic conditions. This innovative blood separation system includes a chamber designed to separate blood into distinct components. It features an outlet line for the removal of the first blood component and is equipped with a primary optical sensor assembly to monitor the interior of the separation chamber. Additionally, a secondary optical sensor assembly is utilized to monitor the first blood component in the outlet line. The system is programmed to select between these sensor assemblies to ensure the contamination of the first blood component is effectively monitored. This technology is particularly beneficial in preventing contamination of separated plasma that is lipemic or hemolytic.
Career Highlights
Christopher Mikkelson is currently employed at Fenwal, Inc., where he continues to develop innovative solutions in blood management. His work has been instrumental in advancing the capabilities of blood separation systems, contributing to improved patient outcomes.
Collaborations
Mikkelson has collaborated with notable colleagues, including John T. Foley and Lan T. Nguyen, who have also contributed to advancements in the field of blood technology.
Conclusion
Christopher Mikkelson's work in blood separation technology exemplifies the impact of innovation in healthcare. His patents reflect a commitment to enhancing the safety and efficiency of blood component management, ultimately benefiting patients and medical professionals alike.